11βmethyl nortestosterone dodecylcarbonate
- Generic Name
- 11βmethyl nortestosterone dodecylcarbonate
Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
Phase 1
- Conditions
- Healthy MenMale Contraception
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 12
- Registration Number
- NCT02754687
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸University of Washington, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath